Regulatory Challenges Ahead
The regulatory landscape for new animal drugs in the US poses significant challenges, often extending approval timelines to eight years. Public perception plays a crucial role in the adoption of these technologies, as past experiences with productivity-enhancing products have led to consumer distrust. A coordinated global effort involving various stakeholders is essential to effectively address enteric methane emissions and maximize reduction strategies.In this clip
From this podcast
Catalyst with Shayle Kann
Solving the cow burp problem
Related Questions